Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 1INDUSTRY 1FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Radiation Pneumonitis 1Neoplasm Metastasis 1Lung Neoplasms 1Hypertension 1Essential Hypertension 1Breast Neoplasms 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Has results × Enalapril × Clear all
NCT01754909 2019-10-08

Mitigation of Radiation Pneumonitis and Fibrosis

VA Office of Research and Development

Phase 2 Completed
50 enrolled 10 charts
Thoracic

Lung Neoplasms, Radiation Pneumonitis

NCT00895414 2019-05-08

Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer

Masonic Cancer Center, University of Minnesota

Phase NA Completed
19 enrolled 3 charts
Breast

Breast Neoplasms

NCT01151410 2016-03-07

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

Novartis

Phase 3 Completed
208 enrolled 10 charts

Essential Hypertension, Hypertension, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡